Seventy crossbred heifers were allotted randomly to 10 treatment groups. Treatments consisted of active immunization against ovalbumin (OV) conjugates of luteinizing hormone-releasing hormone (LHRH), human chorionic gonadotropin (hCG) and bovine luteinizing hormone (bLH) with each of three adjuvants. The adjuvants were complete Freund's adjuvant (CFA), M1036 and 6VR ~ . Control animals were immunized against OV alone using CFA. Bulls were placed with the heifers following immunization to allow comparison of pregnancy rates between groups. Blood samples were collected weekly for 14 wk to determine antibody concentrations. Significant levels of circulating LH or LHRH antibodies were detected in heifers immunized with each of the hormone conjugates. Complete Freund's adjuvant was the most effective for stimulating antibody response to these antigens; however, M103 was equally effective when used with bLH or hCG conjugates. None of the heifers in the bLH-OV-CFA, bLH-OV-M103 or LHRH-OV-CFA immunization groups was pregnant at slaughter, whereas 71% of the OV-CFA control heifers were pregnant. Fertility suppression may be achieved in the bovine by active immunization against any of these three hormone conjugates. However, the duration of this study (8 wk of prostaglandin F 2 alpha (PGF2a) to abort pregnant heifers entering the feedlot. The disadvantages of these procedures are the cost of spraying and PGF2a and possible mortality. One alternative approach to the problem would be to sterilize heifers by vaccination against a reproductive hormone. If the luteinizing hormone (LH) surge occurring in serum prior to ovulation could be blocked by immunoneutralization, the heifer would fail to ovulate, and pregnancy would be prevented. Active immunization against LH releasing hormone (LHRH) decreases LH release and causes gonadal trophy (Clarke et al., 1978; Schanbacher, 1982; Fraser, 1983; Esbenshade and Britt, 1985; Adams and Adams, 1986; Falvo et al., 1986; Garza J. et al., 1986) in several species. Active immunization against LH (Fraser and Baker, 1978; Talwar, 1986) reduced fertility in female rats and primates and reduced gonadal weight and function in male cattle (Schanbacher, 1985) . The objectives of this study were 1) to stimulate the production of antibodies to LHRH and bovine LH (bLH) in heifers, 2) to evaluate the relative effectiveness of complete Freund's adjuvant (CFA), M103
of prostaglandin F 2 alpha (PGF2a) to abort pregnant heifers entering the feedlot. The disadvantages of these procedures are the cost of spraying and PGF2a and possible mortality. One alternative approach to the problem would be to sterilize heifers by vaccination against a reproductive hormone.
If the luteinizing hormone (LH) surge occurring in serum prior to ovulation could be blocked by immunoneutralization, the heifer would fail to ovulate, and pregnancy would be prevented. Active immunization against LH releasing hormone (LHRH) decreases LH release and causes gonadal trophy (Clarke et al., 1978; Schanbacher, 1982; Fraser, 1983; Esbenshade and Britt, 1985; Adams and Adams, 1986; Falvo et al., 1986; Garza J. et al., 1986) in several species. Active immunization against LH (Fraser and Baker, 1978; Talwar, 1986) reduced fertility in female rats and primates and reduced gonadal weight and function in male cattle (Schanbacher, 1985) . The objectives of this study were 1) to stimulate the production of antibodies to LHRH and bovine LH (bLH) in heifers, 2) to evaluate the relative effectiveness of complete Freund's adjuvant (CFA), M103 (an experimental water in oil adjuvant) and 6VR (an experimental oil in water adjuvant) for inducing antibodies and 3) to evaluate the shortterm effects of active immunization against these hormones on fertility.
Materials and Methods
Animals and Treatments. Seventy crossbred heifers (mean weight 364 kg) were stratified by weight and randomly assigned to 10 treatment groups. All but one of the heifers were cycling prior to treatment, as determined by serum progesterone concentrations. The one noncycling heifer had cycled by wk 3 into the study. Three hormone conjugates were tested with each of three adjuvants; control heifers received only ovalbumin (OV) in CFA. Hormone-OV conjugates tested were LHRH-ovalbumin (LHRH-OV), human chorionic gonadotropin (hCG) ovalbumin (hCG-OV) and bLH-ovalbumin (bLH-OV). Adjuvants tested within each hormone conjugate group were CFA, M103 and 6VR. Control heifers were immunized with OV alone in CFA. Each treatment group contained seven heifers. Following the last of 3 immunizations (wk 6), the heifers were maintained in three pens with two bulls per pen. Bulls were rotated to a different pen of heifers every 14 d throughout the study period, which lasted 14 wk.
Preparation of Antigens and Immunization.
Bovine LH (.61 • NIH-LH-B7 relative potency), purified from bovine pituitaries (Licht et al., 1977) , and hCG (Sigma CGB, 3326 IU/mg) were conjugated to OV using glutaraldehyde as the coupling agent (Reichlin, 1980) . Briefly, 110 mg of bLH and 45 mg of OV (Sigma grade V) were dissolved in 10 ml .1M phosphate buffered saline (PBS), pH 7.0. With constant stirring, 3.5 ml of 2.8% glutaraldehyde solution in .1M PBS, pH 7.0, was added dropwise to the LH/OV solution. The reaction was allowed to proceed for 24 h at room temperature with constant stirring. The solution was then dialized (molecular wt cutoff 12,000 to 14,000) against .005M PBS, pH 7.0, for 24 h at 4 C and was subsequently lyophilized. Human chorionic gonadotropin was conjugated using "the same procedure described for LH.
Luteinizing hormone releasing hormone was conjugated on OV using the carbodiimide method (Bauminger and Wilchek, 1980) . Ten milligrams of OV were dissolved in 5 ml of distilled ~ Amersham Co., Arlington Heights, IL.
water. Thirty milligrams of LHRH (NIH-LHRH/ FSHRH, amide form, lot #19-192AL) were added to the OV solution, followed by addition of 100 mg of carbodiimide (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride). The reaction was allowed to proceed for 30 min at room temperature and then continued for 3 h at 4 C. The pH was maintained at 6.0 during the entire reaction time. The solution then was dialyzed (molecular wt cutoff 12,000 to 14,000) against distilled water for 24 h at 4 C and lyophilized. Control animals were immunized with OV alone.
Each hormone conjugate was emulsified in each of three different adjuvants, CFA, M103 adjuvant and 6VR adjuvant. The CFA was prepared using the exact ingredients found in the commercial preparation with M. paratuberculosis as the immunostimulant. The M103 adjuvant and the 6VR adjuvant contain Quillaba saponin (1 mg/ml) as the immunostimulant.
The M103 adjuvant contains 63% oil and 37% water and the 6VR adjuvant contains 5% oil and 95% water.
In the four CFA groups (bLH-OV, hCG-OV, LHRH-OV, OV) the initial immunization consisted of 1 mg of antigen conjugate dissolved in 1 ml .9% NaC1 emulsified in 1 ml CFA. Two booster injections using incomplete Freund's adjuvant were prepared in the same manner. The primary immunizations and boosters in the M103 and 6VR adjuvant groups were prepared identically. One milligram of antigen conjugate (bLH-OV, hCG-OV, LHRH-OV) was emulsified in 1 ml of each adjuvant for each injection. Each heifer received three injections at 2-wk intervals at two s.c. sites in the dewlap.
Data Collection and Blood
Samples. Blood samples were collected weekly for 14 wk via jugular venipuncture to determine progesterone concentrations and bLH or LHRH antibody concentrations. Cyclicity was determined from serum progesterone concentrations and observations for estrus made twice daily. At slaughter, ovaries were collected, and reproductive tracts were examined for signs of pregnancy. Stage of pregnancy was determined by fetal crown-rump length and serum progesterone profiles.
Assays. Blood samples were allowed to clot for 24 h at 4 ~ C and centrifuged, and the serum was stored at -20 ~ C until assayed for progesterone and hormone antibody concentrations. Weekly progesterone was measured by a validated single antibody radioimmunoassay using (1,2,6,7a-3H) progesterone 7 as the tracer and CFC-#4 as the progesterone antibody (Chang et al., 1987) . Intra-assay and inter-assay coefficients of variation were 2.4 and 15.8%, respectively.
To evaluate antibody concentrations in the bLH, hCG and control immunized heifers, serum samples were diluted 1 : 8,000 in ethylenediaminetetraacetate (EDTA)-PBS containing .25% normal bovine serum, pH 7.0 (.05 M EDTA, .01 M sodium phosphate, .14 M sodium chloride , .01% merthiolate with phenol red). Two hundred pl of the diluted serum were added to assay tubes containing 500 gl PBS-gel at pH 7.0 (.1% gelatin). The serum was incubated for 48 h at 4 ~ C with 30,000 cpm iodinated ovine LH (LER-1056-C2; Greenwood et al., 1963) in 100 /~1 PBS-gel. Following the 48-h incubation, 200 ~1 of goat anti-bovine gamma globulin diluted 1:5 in PBS-gel was added as a second antibody to precipitate the antibody-bound labeled hormone. The assay tubes were again incubated at 4 ~ C for 48 h, following which 1 ml of PBS (pH 7.0) was added. Tubes were then centrifuged, the supernatant fluid was poured off, and the pellet was counted for bound radioactivity.
The LHRH antibody samples and control samples were diluted 1:1,000 in EDTA-PBS, pH 7.0, with .25% normal bovine serum. Incubation times, buffers and procedures were exactly the same as for bLH and hCG with 30,000 cpm iodinated LHRH added per tube. The LHRH was iodinated according to the method of Reeves et al. (1982) . Nonspecific binding was calculated by averaging the radioactivity bound in the precipitate of the sample prior to any immunization. Percentage of binding was calculated by subtracting the nonspecific binding from the total radioactivity bound in the precipitate of the serum sample and dividing by the total counts added. The values were corrected for bindability of the labeled hormone. Results are expressed as percentage of labeled hormone bound for each sample.
Statistical Analysis. Antibody binding was
analyzed by analysis of variance for repeated measures (Gill and Hafs, 1971) . Antibody binding was analyzed separately for the first 6 and the last 8 wk. Differences between adjuvants within hormone groups were evaluated using orthogonal contrasts. Pregnancy rates were analyzed by chi-square analysis. Progesterone concentrations were not analyzed statistically and were only used to make decisions on cyclicity and length of pregnancy. Mean antibody binding in a) luteinizing hormone releasing hormone (LHRH), b) human chorionic gonadotropin (hCG) and c) bovine luteinizing hormone (bLH) immunized heifers. Arrows (*) indicate immunization schedule. Binding is expressed as %125-I-LHRH or %125-I-ovine luteinizing hormone (oLH) bound during a 48-h incubation period. Serum from heifers immunized against LHRH was diluted 1:1,000. Serum from heifers immunized against hCG and bLH was diluted 1:8,000. CFA = complete Freund's adjuvant; M103 and 6 VR are experimental adjuvants (63% oi1:37% water and 5% oi1:95% water, respectively); control heifers received only ovalbumin in CFA. mean antibody binding between the LHRH-OV-6VR and OV-CFA (control) immunized heifers (P > .05). During this period, antibody binding in LHRH-OV-MI03 and LHRH-OV-CFA immunized heifers was not different (P > .05), but both were higher than mean antibody binding in LHRH-OV-6VR and OV-CFA (control) immunized heifers (P < .05). Analysis of antibody binding over time using a linear contrast indicated that the change in mean antibody binding over time differed between the treatments (P < .001). Antibody binding in the LHRH-OV-MI03 and LHRH-OV-CFA immunized heifers increased to 16% by wk 8. Antibodies remained at this level in the LHRH-OV-M103 group throughout the rest of the study period. In contrast, antibody binding in the LHRH-OV-CFA immunized heifers continued to increase to 36% by wk 14.
Results

Heifers Immunized with Luteinizing
Four of the seven heifers (57%) in the LHRH-OV-6VR immunized group were pregnant at slaughter, which was similar (P > .05) to the pregnancy rate in the OV-CFA (control) immunized heifers (71%; Figure 2 ). Pregnancy rates in the LHRH-OV-MI03 (14%) and LHRH-OV-CFA (0%) immunized heifers were lower (P < .05). Within these two groups the ovaries of 9 out of 11 heifers contained small (.5-cm) follicles but no large follicles or corpora lutea, indicative of suppression of fertility. When ovaries from noncycling heifers (those without corpora lutea) were weighed, the LHRH immunized heifers had smaller (P < .05) ovaries (3.5 + .3 g; mean + SE) than either hCG (4.9 + .67 g) or bLH (5.5 + .5 g) immunized heifers. In the LHRH-OV-M103 immunized heifers it was apparent that as antibodies to LHRH were produced progesterone concentrations in serum decreased.
Heifers immunized against LHRH-OV-CFA had depressed fertility due to production of antibodies to LHRH. An example of an LHRH-OV-CFA immunized heifer (Figure 3a) shows cyclicity prior to the increase in LHRH-antibody binding, as illustrated by progesterone patterns. As antibody binding in the serum increased, progesterone concentrations decreased to undetectable levels and remained undetectable for the rest of the study. This pattern was characteristic of heifers that displayed antibody binding of this magnitude.
Heifers Immunized with Human Chorionic
Gonadotropin. Antibody binding of 125-1-LH in all hCG-OV immunized heifers was higher than in OV-CFA (control) immunized heifers during the first 6 wk (P < .001; Figure lb) . Mean antibody binding was not different between the hCG-OV-CFA immunized heifers and the other two adjuvant groups (P > .05), but antibody binding was higher in the hCG-OV-M103 immunized heifers than in those immunized with hCG-OV-6VR (P < .001).
There was no difference (P > .05) in antibody binding between the hCG-OV-M103 and hCG-OV-CFA immunized heifers from wk 7 to wk 14. Mean antibody binding in the hCG-OV-6VR and OV-CFA (control) immunized heifers did not differ (P > .05), but both were lower than in hCG-OV-M103 and hCG-OV-CFA immunized heifers (P < .05). There was no change in antibody binding over this 8-wk period in hCG-OV-MI03 and hCG-OV-CFA immunized heifers. In contrast, antibody binding in hCG-OV-6VR immunized heifers decreased through this period of the study to 8% by wk 14.
One of the seven heifers in the hCG-OV-6VR immunization group was pregnant at slaughter (Figure 2 ). In this heifer, antibody binding increased to 15% by wk 6, but decreased to 2% by wk 9, at which time she cycled and became pregnant. An example of a heifer that began cycling as antibody titers decreased is shown in Figure 3b . This heifer was cycling prior to the increase in antibody binding in the serum, but as antibody binding increased, progesterone 100 80
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Figure 2. Pregnancy rates of control, luteinizing hormone releasing hormone (LHRH), human chorionic gonadotropin (hCG) and bovine luteinizing hormone (bLH) immunized heifers in each adjuvant group. Pregnancy rates are expressed as the percentage of heifers in each group that were pregnant at slaughter (n = 7). *Indicates P < .05 compared with controls. CFA = complete Freund's adjuvant; M103 and 6 VR are experimental adjuvants (63% oi1:37% water and 5% oil: 95% water, respectively); control heifers received only ovalbumin in CFA. ers in this group in which antibody binding A.. decreased to 10% or less during the study. -8
There were no pregnancies in the hCG-OV-M103 immunized heifers, and antibody binding -6 of labeled LH did not drop below 30% in any of the heifers during the study period. Ovaries " collected from 4 of 6 heifers contained follicu--4 lar development (1.0 to 2.0 cm), but no cor-" pora lutea; serum progesterone concentrations 9 2
were not detectable. Antibody binding in hCG-OV-CFA heifers was not different from that in hCG-OV-M103 immunized heifers (P > .05), B, ~ ~ but four of the seven heifers in the CFA adju-! 8 _~ vant group exhibited cyclic activity as indicated by cyclic progesterone concentrations and the t 6 ~ presence of corpora lutea. Two of these heifers were pregnant at slaughter. was different between adjuvant groups (P < .001) during the 8-wk period following the last "*" i'~'" "" booster. Antibody binding decreased from 38% to 11% in the bLH-OV-6VR immunized heifers, and from 42% to 28% in the bLH-OV-M103 immunized heifers, over this period. In contrast, antibody binding did not decrease in the LH-OV-CFA immunized heifers. Mean antibody binding between all three adjuvant groups and the control group was different (P < .05) during this part of the study. Pregnancy rates in the LH immunized heifers were lower than in the OV-CFA immunized (control) heifers (P < .05 ; Figure 2 ). The pregnancy rate in the LH-OV-6VR immunized heifers was 14%, representing one heifer; whereas no pregnancies were detected in either the bLH-OV-ml03 or bLH-OV-CFA immunized heifers.
Antibody binding was greater than 30% by wk 6 in bLH-OV-6VR immunized heifers. However, in six of the seven heifers, antibody binding had decreased to 10% or less by the end of the study. Standing estrus and cyclic progesterone patterns were observed in four of the six heifers after antibody binding had decreased. 
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:~ ' 4 ' 6 ' B lb WEEK Figure 3 . A) Example of a heifer immunized against luteinizing hormone releasing hormone (LHRH) in which progesterone levels decreased to undetectable levels as LHRH antibody binding of 125-I-LHRH increased. B) Example of a heifer immunized against human chorionic gonadotropin (hCG) that resumed cycling following the decrease in antibody binding of 125-I ovine luteinizing hormone (oLH). C) Example of a heifer immunized against bovine luteinizing hormone (bLH) in which progesterone levels in the serum were not detectable following the increase in antibody binding of 125-1-oLH. Observed standing estrus is indicated by E in all examples.
concentrations decreased to undetectable levels. After antibody binding decreased to 10% at wk 11, the heifer cycled at wk 12 and progesterone concentrations were increased again by wk 13. This resumption of cycling was typical of heir-One of these heifers was pregnant at slaughter.
Only two bLH-OV-M103 immunized heifers had antibody binding less than 10% by wk 14, but progesterone remained undetectable in the serum. In these heifers and the bLH-OV-CFA immunized heifers, though follicular development (1.0 to 2.0 cm) was present on all ovaries collected, fertility depression was accomplished. An example of antibody binding and progesterone concentrations of a heifer in the bLH-OV-CFA group is shown in Figure 3c . Progesterone concentrations in the serum were not detectable following the first booster, and they remained undetectable throughout the study in all bLH-OV-CFA immunized heifers.
Discussion
Adjuvant Performance. The 6VR adjuvant was not effective in stimulating antibody production to LHRH and was the least effective adjuvant in maintaining antibody production to bLH. In LH and hCG immunized heifers, the 6VR adjuvant induced antibody formation to bLH as well as the M103 and CFA adjuvants, but it was inferior in maintaining antibody production. The M103 adjuvant was comparable with CFA in its ability to induce and maintain antibody binding when used to immunize against hCG, but was less effective than CFA when used to immunize against LH or LHRH. This hormone by adjuvant interaction (P < .001) indicates that there may be an optimum hormone-adjuvant combination to stimulate antibody production to a particular hormone conjugate. The CFA adjuvant was the most effective in the stimulation and maintenance of antibody titers when used to immunize against each of the hormone conjugates.
The adjuvants 6VR and M103 contain the same amount of Quillaba saponin as a combination immunostimulant and emulfisying agent, yet they differ in their stimulation and maintenance of antibody binding. This could be due to the difference in oil content of these two adjuvants. The 6VR adjuvant, containing less oil, is less effective in inducing and maintaining antibody production than the M103 adjuvant. The M103 adjuvant possibly keeps the antigen in the system longer due to its higher oil content, thus causing stimulation of the immune system over a longer period of time. The CFA adjuvant contains the highest percentage of oil and was superior to the other two adjuvants in inducing antibodies to L!HRH and bLH but not in the induction of hCG antibodies that were effective in neutralizing bLH, The immunostimulant is different in CFA (M. paratuberr losis), which may account for its superiority in antibody induction and maintenance.
Immunization. against Luteinizing Hormone Releasing Hormone. Active immunization against LHRH, resulting in decreased fertility, was accomplished' in heifers using the M103 adjuvant and CFA. Serum progesterone concentrations were depressed or not detectable in heifers with antibody binding of over 20%.
In studies using the CFA adjuvant to actively immunize against LHRH in other species, antb body production and impairment of reproductive function were similar to those in the present study. In rats, active immunization against LHRH resulted in antibody production and inhibition of ovulation, but follicular development was present at various degrees (Fraser and Baker, 1978) . The ovaries of heifers showing LHRH antibody binding in the present study did not have follicular development and in most cases were small, with no structures. Antibodies to LHRH have been generated in mares, resulting in a reproductive state similar to seasonal anestrus (Garza et al., 1986) . As in the present study, ovarian weights, number of follicles greater than 10 mm and number of corpora lutea present were lower in immunized mares than in control mares. Active immunization against LHRH in gilts inhibited LH, folliclestimulating hormone (FSH) and gonadal steroid secretion and induced acyclic reproductive states (Esbenshade and Britt, 1985) . lmmuni, zation against LHRH in female monkeys resuited in ammenorrhea (Fraser, 1983) . Active immunization against LHRH in the ewe resuited in the failure to show estrus or to ovu, late, and levels of plasma LH were lower than in controls (Clarke et al., 1978; Adams and Adams, 1986) . Ovaries of our LHRH immunized heifers were smaller than those of either hCG or LH immunized heifers, suggesting the lack of both LH and FSH stimulation in the LHRH immunized heifers.
Immunization agains t Human Cborionic Go, nadotropin and Bovine Luteinizing Hormone.
Antibodies capable of binding iodinated ovine LH (125-I-oLHH) were generated in all heifers actively immunized against hCG. Even though antibodies generated to hCG-OV were comparable in binding of 125-boLH between the M103 and CFA adjuvant groups, the antibodies acted differently in vivo. Heifers immunized against hCG-OV using the M103 adjuvant produced antibodies capable of depressing fertility, as indicated by ovaries containing only follicular development and by undetectable serum progesterone concentrations. In contrast, antibodies produced in the CFA adjuvant group were not effective in suppressing fertility; even though antibody binding was as high as in the M103 adjuvant group, the heifers still cycled as indicated by cyclic progesterone patterns and ovaries containing corpora lutea.
It has been shown in monkeys that hCG antibodies induced by active immunization crossreact with LH in vitro but do not disrupt LH biological action in vivo (Hearn, 1979) . Similarly, in the present study, hCG antibodies induced in the CFA group did not impair cyclic function of these heifers. It is difficult to explain why the antibodies in these two groups, although showing identical binding in vitro, have different biological actions in their ability to neutralize endogenous LH and prevent cyclicity. The immunostimulants in the M103 and CFA adjuvants may account for the difference in effectiveness of the antibodies produced.
Coupling of bLH to OV made it immunogenic, resulting in bLH antibody production in all heifers in all three adjuvant groups. This is consistent with a previous study in which cows and heifers were actively immunized against bLH using the same hormone conjugate in CFA adjuvant (De Silva et al., 1986) . Resumption of cycling in the 6VR group occurred when antibody binding of 125-I-oLH in the serum decreased. This observation is consistent with studies using primates in which fertility was regained at low LH antibody titers (Talwar et al., 1986) . The decrease in antibody binding was consistent within the 6VR group and, although only one heifer was pregnant at slaughter, the pregnancy rate may have been comparable to that of controls had the study continued longer.
Serum progesterone concentrations were undetectable in all heifers in the M103 and CFA groups from wk 5 through the end of the study, indicating virtually complete acyclic states. Follicular development on the ovaries of these heifers indicates that the antibodies generated against bLH did not impair follicle stimulating hormone (FSH) function at the level of the ovary. DeSilva et al. (1986) , using the same conjugate, also showed no change in circulating FSH after immunization. Similarly, in rats actively immunized against bLH, ovulation was prevented, but follicular development was not adversely affected (Laurence and Ichikawa, 1968) .
In conclusion, antibodies can be produced against LHRH, hCG and bLH in heifers by active immunization procedures; these antibodies interfere with normal reproductive function. The adjuvant used in conjunction with a hormone conjugate plays an important role in both the exposure of the antigen to the immune system and the stimulation of antibody production. The adjuvant may perform differently depending on which antigen is used. In our study, the bLH-OV conjugate was the most consistent antigen for the stimulation and maintenance of antibodies and prevention of pregnancy. If antibody titers could be maintained over a sufficient period, active immunization against bLH holds promise for a vaccine to prevent pregnancy.
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